🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseHad a FibroScan and do not understand my results - help — 6 month update Page 2

Had a FibroScan and do not understand my results - help — 6 month update

LibrarianMeg Sat, Feb 7, 2026 at 8:45 PM 11 replies 964 viewsPage 2 of 3
amsterdam_pete
Senior Member
1,567
6,789
Feb 2024
Netherlands
Feb 7, 2026 at 11:10 PM#6
DebRD_ATL said:
Liver imaging follow-up for liver and MASH: FibroScan at baseline showed CAP score 332 dB/m (moderate steatosis) and stiffness 10.8 kPa (possible…

Liver ultrasound comparison for liver and MASH: my hepatologist ordered serial ultrasounds to track NAFLD regression.

Baseline: "Moderate hepatic steatosis, liver span 17.2cm, echogenic texture consistent with fat infiltration"
Month 8: "Mild steatosis, liver span 15.8cm, improved echogenicity"
Month 14: "Minimal to no steatosis, normal liver span 14.5cm, normal echotexture"

My liver literally shrank and de-fattened. The ultrasound tech said she's seen this pattern increasingly in GLP-1 patients and it's remarkable how consistently the fatty liver resolves.

1 21JakeSmashed95
Reply Quote Save Share Report
FDA_TrackerJim
Senior Member
1,567
7,890
Feb 2024
Rockville, MD
Feb 8, 2026 at 12:06 AM#7
LibrarianMeg said:
Fatty liver on an incidental scan two years ago and nobody followed it up.

Liver enzyme update related to liver and MASH: I had mildly elevated ALT/AST at baseline (likely NAFLD). After 9 months on GLP-1 therapy:

MarkerBaselineCurrentNormal Range
ALT59317-56 U/L
AST672710-40 U/L
GGT74319-48 U/L
ALP1148144-147 U/L

FibroScan also improved — liver stiffness from 8.5 kPa to 6.2 kPa. The evidence for GLP-1 agonists in NAFLD/NASH is very promising.

Last edited: Feb 8, 2026 at 3:06 AM
50 20Admin, Dr.Martinez, mike_mod and 47 others
Reply Quote Save Share Report
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
Feb 8, 2026 at 1:02 AM#8
amsterdam_pete said:
Liver ultrasound comparison for liver and MASH: my hepatologist ordered serial ultrasounds to track NAFLD regression.

There is a second half to this that has not been said yet. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

Last edited: Feb 8, 2026 at 4:02 AM
49 19MaxMetOK, MounjBrad, nick_newbie and 46 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.NephBHM_UK
Member
456
2,123
Jun 2024
Birmingham, UK
Feb 8, 2026 at 1:58 AM#9

One thing that is still open after stefan_berlin’s answer:

What would you measure differently if you were starting again?

Last edited: Feb 8, 2026 at 7:58 AM
48 18SurmountFan_IN, PeptideChemSF, A1cHero_PHX and 45 others
Reply Quote Save Share Report
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Feb 8, 2026 at 6:29 AM#10

Reporting back.

Closing the loop. The answer turned out to depend on the detail I had left out of the opening post, which is a lesson about how to ask rather than about the subject.

Last edited: Feb 8, 2026 at 8:29 AM
18 16TomFromTexas, mike.trainer_LA, sarah_nash92 and 15 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register